Tuning of antibacterial activity of a cyclopropyl fluoroquinolone by variation of the substituent at position C-8
Open Access
- 21 September 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (12) , 2801-2808
Abstract
If substituted at position C-8 by a methoxy group, fluoroquinolones possess antibacterial efficacy considerably improved over that of C-H analogues. The new veterinary fluoroquinolone pradofloxacin bears a cyano group at C-8 and it was attempted to define the ranges of activity unfolding upon variation of this moiety. Pradofloxacin and six analogues were subjected to MIC and mutant prevention concentration (MPC) analysis; we determined comparative activities against one wild-type and two isogenic first-step fluoroquinolone-resistant variants each of Escherichia coli and Staphylococcus aureus. Ciprofloxacin, enrofloxacin and its 8-CN analogue, the R,R-pyrrolidinopiperidine enantiomer of pradofloxacin as well as the 8-OH congener of pradofloxacin served as references. MICs were of limited utility in resolving differences in antibacterial activity. Regarding MPCs, E. coli was inhibited most effectively by ciprofloxacin. However, pradofloxacin and analogues bearing Cl or F closely matched that activity. MPCs of O-alkyl and the R,R-pyrrolidinopiperidine-substituted compounds indicated lower activities, while the 8-OH metabolite, essentially, had lost activity. Replacement of 8-H by CN, resulting in up to 7-fold reduced MPCs, was a prerequisite for high activity against the wild-type strains and first-step fluoroquinolone-resistant variants. Narrowed mutant selection windows, observed for both variants of E. coli and wild-type S. aureus, indicated an improved potential of pradofloxacin for restricting the selection of clones with reduced susceptibility. Substitution of hydrogen at position C-8 of an analogue of pradofloxacin by CN provided for MPCs lower than those of 8-O-CH3 and almost similar to C-8-halogenated compounds, while alkoxy substituents caused reduced activity and hydroxylation resulted in inactivation. Efficacy was co-dependent on the amine moiety located at C-7.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of the Clinical Efficacy of Pradofloxacin Tablets for the Treatment of Canine PyodermaJournal of the American Animal Hospital Association, 2010
- Evaluation of pradofloxacin for the treatment of feline rhinitisJournal of Feline Medicine and Surgery, 2008
- A unified anti-mutant dosing strategyJournal of Antimicrobial Chemotherapy, 2008
- Mutant Selection Window Hypothesis UpdatedClinical Infectious Diseases, 2007
- In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutantsJournal of Antimicrobial Chemotherapy, 2004
- Mutant Selection Window in Levofloxacin and Moxifloxacin Treatments of Experimental Pneumococcal Pneumonia in a Rabbit Model of Human TherapyAntimicrobial Agents and Chemotherapy, 2004
- Restricting the Selection of Antibiotic‐Resistant Mutants: A General Strategy Derived from Fluoroquinolone StudiesClinical Infectious Diseases, 2001
- Effect of Fluoroquinolone Concentration on Selection of Resistant Mutants of Mycobacterium bovis BCG and Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1999
- The Development of Vancomycin Resistance in a Patient with Methicillin-ResistantStaphylococcus aureusInfectionNew England Journal of Medicine, 1999
- DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistanceProceedings of the National Academy of Sciences, 1997